Biocryst Pharmaceuticals reported $13.88M in Trade Creditors for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
DBV Technologies DBVT:US 11.42M 13K
Alnylam Pharmaceuticals ALNY:US $ 54.92M 18.51M
Biocryst Pharmaceuticals BCRX:US $ 13.88M 13.93M
Chemocentryx CCXI:US $ 5.42M 1.32M
Daiichi Sankyo 4568:JP Y 324784M 49835M
Enanta Pharmaceuticals ENTA:US $ 5.98M 1.86M
Gilead Sciences GILD:US $ 583M 122M
Intra Cellular Therapies ITCI:US $ 11.65M 2.96M
IONIS PHARMACEUT IONS:US $ 16.12M 4.22M
Karyopharm Therapeutics KPTI:US $ 3.44M 1.84M
Mirati Therapeutics MRTX:US $ 27.94M 7.22M
Novavax NVAX:US $ 135.13M 8.08M
Ptc Therapeutics PTCT:US $ 18.36M 4.67M
Regeneron Pharmaceuticals REGN:US $ 470.3M 93.7M
Sarepta Therapeutics SRPT:US $ 54.01M 22.73M
Ultragenyx Pharmaceutical RARE:US $ 23.68M 6.55M
Vertex Pharmaceuticals VRTX:US $ 173.6M 21.4M
YTE INCY:US $ 152.55M 19.56M